At this stage, the company appears to be operating on cash from the exercise of warrants and options, and that’s contributing to the downward pressure on the share price. Three million newly issued shares over the past two weeks and ~20 million since June 28th, for a modesty traded OTC stock is an awful lot.
The 10Q ended 6/30 should be interesting to see where their cash is coming from if other than just warrants. And whether any sweeteners were offered.